The Committee on Proprietary Medicinal Products Safety Working Party's Recommendations to Minimise the Unnecessary Use of Animals in the Evaluation of New Medicines
Restricted accessOtherFirst published online June, 1984
The Committee on Proprietary Medicinal Products Safety Working Party's Recommendations to Minimise the Unnecessary Use of Animals in the Evaluation of New Medicines
GriffinJ.P. (1981). Referring to the paper by Zbinden and Flury-Roversi.Archives of Toxicology49, 99–103.
2.
DraperM.H., and GriffinJ.P. (1980). Draft guidelines on mutagenicity testing of new drugs issued by the CPMP.Archives of Toxicology46, 9–19.
3.
Commission of the European Communities (1984). The rules governing medicaments in the European Community. EEC Brussels/Luxembourg (this includes all Directives and Guidelines issued by the European Communities).
4.
Commission of the European Communities (1984). Proposal for a Council Directive amending Directive 75/318/EEC on the approximation of the laws of the member states relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products.Official Journal of the European Communities27, 5th November 1984, 84/C 293/02.
